We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Affymetrix, Inc. | NASDAQ:AFFX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 14.01 | 0 | 01:00:00 |
Kythera Biopharmaceuticals, Inc. (KYTH) was a big mover last session, as the company saw its shares surge by more than 25% on the day. The move came on solid volume too, as far more shares changed hands than in a normal session. This continues the recent uptrend for the company, as the stock has gained more than 78% in the past one-month time frame.
The company has seen two negative revisions and a single positive revision in the past two months. Also, its earnings consensus has moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent rally can last.
KYTH currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Some better performing Med-BioMed/Gene stocks include Actelion Ltd. (ALIOF), Affymetrix Inc. (AFFX) and Gilead Sciences Inc. (GILD). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
1 Year Affymetrix Chart |
1 Month Affymetrix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
